Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
AKT is a critical regulator of rRNA synthesis and cooperates with c-MYC to control ribosome biogenesis in cancer
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
788014
Author(s)
Chan, J. C.; Hannan, K. M.; Riddell, K.; Ng, P. Y.; Peck, A.; Lee, R. S.; Hung, S.; Astle, M. V.; Bywater, M.; Wall, M.; Poortinga, G.; Jastrzbeski, K.; Sheppard, K. E.; Hemmings, B. A.; Hall, M. N.; Johnstone, R. W.; McArthur, G. A.; Hannan, R. D.; Pearson, R. B.
AKT is a critical regulator of rRNA synthesis and cooperates with c-MYC to control ribosome biogenesis in cancer
Journal
Science Signaling
Volume
4
Number
188
Pages / Article-Number
ra56
Abstract
Precise regulation of ribosome biogenesis is fundamental to maintain normal cell growth and proliferation, and accelerated ribosome biogenesis is associated with malignant transformation. Here, we show that the kinase AKT regulates ribosome biogenesis at multiple levels to promote ribosomal RNA (rRNA) synthesis. Transcription elongation by RNA polymerase I, which synthesizes rRNA, required continuous AKT-dependent signaling, an effect independent of AKT\u2019s role in activating the translation-promoting complex mTORC1 (mammalian target of rapamycin complex 1). Sustained inhibition of AKT and mTORC1 cooperated to reduce rRNA synthesis and ribosome biogenesis by additionally limiting RNA polymerase I loading and pre-rRNA processing. In the absence of growth factors, constitutively active AKT increased synthesis of rRNA, ribosome biogenesis, and cell growth. Furthermore, AKT cooperated with the transcription factor c-MYC to synergistically activate rRNA synthesis and ribosome biogenesis, defining a network involving AKT, mTORC1, and c-MYC as a master controller of cell growth. Maximal activation of c-MYC\u2013dependent rRNA synthesis in lymphoma cells required AKT activity. Moreover, inhibition of AKTdependent rRNA transcription was associated with increased lymphoma cell death by apoptosis. These data indicate that decreased ribosome biogenesis is likely to be a fundamental component of the therapeutic response to AKT inhibitors in cancer.
Publisher
American Association for the Advancement of Science